Survodutide: difference between revisions
Diff·revision 17 → 18·04:09, 23 Sep 2025
Difference between revision 17 and revision 18 of Survodutide. 2 lines changed; the page grew by 143 bytes.
| Revision 17 — 17:15, 26 Aug 2025 OralSemaOswin (talk) expand §Design and rationale 5,302 bytes ±0 | Revision 18 — 04:09, 23 Sep 2025 ExenatideEzra (talk) attribute the potency comparison to the head-to-head trial rather than to two separate ones 5,445 bytes +143 | ||
|---|---|---|---|
| 34 | Material offered as survodutide by research-chemical suppliers is an unapproved investigational compound. As with [[Retatrutide|retatrutide]], there is no marketed reference product and therefore no generally available [[Reference standard|reference standard]] against which identity could be confirmed by comparison, so a purity figure on a certificate rests on an unverified identity assignment.{{r|usp1503}} | 34 | Material offered as survodutide by research-chemical suppliers is an unapproved investigational compound. As with [[Retatrutide|retatrutide]], there is no marketed reference product and therefore no generally available [[Reference standard|reference standard]] against which identity could be confirmed by comparison, so a purity figure on a certificate rests on an unverified identity assignment.{{r|usp1503}} |
| 35 | 35 | ||
| + | 36 | This wiki records what documents state and does not represent investigational compounds as suitable for human use; see [[Research use only]]. | |
| + | 37 | ||
| 36 | == References == | 38 | == References == |
| 37 | {{reflist}} | 39 | {{reflist}} |